MLYS- Mineralys Therapeutics, Inc.

Name: Mineralys Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Mineralys Therapeutics, Inc. (MLYS) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 13 sells. MLYS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Slingsby Brian Taylor	7.90M	$233.48M	-
Dir	Ra Capital Management, L.P.	5.46M	$161.19M	-
CEO	Congleton Jon	689.3K	$20.36M	-15,730
Dir	Akkaraju Srinivas	588.2K	$17.38M	-
Other	Rodman David Malcom	69.8K	$2.06M	-20,822

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 4, 2025	Akkaraju Srinivas81	Director	Buy	588,235	$25.50	$14,999,992.50	New	+18.4%	-
Aug 13, 2025	Rodman David Malcom58	Chief Medical Officer	Sale+OE	11,365	$12.93	$146,986.95	-10.9%	+247.4%	-
Jul 30, 2025	Levy Adam Scott	CFO And Secretary	Sell	73,678	$14.62	$1,077,476.77	-10.0%	+180.7%	-
Jul 14, 2025	Rodman David Malcom58	Chief Medical Officer	Sale+OE	11,366	$14.59	$165,878.81	-10.4%	+186.6%	-
Jul 11, 2025	Congleton Jon47	Chief Executive Officer	Sell	15,884	$14.51	$230,430.78	-1.8%	+171.8%	-
Jul 11, 2025	Levy Adam Scott	CFO And Secretary	Sell	10,758	$14.45	$155,454.18	-4.9%	+171.8%	-
Jun 13, 2025	Rodman David Malcom58	Chief Medical Officer	Sale+OE	11,366	$14.60	$165,931.10	-10.1%	+159.5%	-
May 14, 2025	Rodman David Malcom58	Chief Medical Officer	Sell	11,366	$15.29	$173,773.64	-9.6%	-10.6%	-
Apr 14, 2025	Rodman David Malcom58	Chief Medical Officer	Sale+OE	11,366	$14.53	$165,185.14	-4.7%	+7.9%	+91.2%
Apr 11, 2025	Levy Adam Scott	CFO And Secretary	Sell	10,757	$12.06	$129,684.24	-4.8%	+9.3%	+98.7%

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC